Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taylor Goodstein

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Current Opinion in Oncology|April 4, 2024
Special populations in metastatic renal cell carcinomaTaylor Goodstein, Ilana Goldberg, Yusuf Acikgoz, et al.
Cancers|April 14, 2026
Using ctDNA to Inform Adjuvant Therapy for Urologic MalignanciesRajvi Goradia, Taylor Goodstein, Debasish Sundi, et al.
Translational Cancer Research|December 19, 2024
Perioperative systemic therapy in high-risk renal cell carcinoma following nephrectomy: a narrative reviewAdam Khorasanchi, Taylor Goodstein, Shawn Dason, et al.
Urologic Oncology|July 2, 2025
Concordance between clinical and pathologic staging of larger (cT2a-b) and more invasive (cT3a) renal cell carcinomaTaylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Clinical Genitourinary Cancer|March 18, 2026
Retraction notice to " Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma"[Clinical Genitourinary Cancer 23/6 (2025) 102422]Taylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Clinical Genitourinary Cancer|September 17, 2025
Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell CarcinomaTaylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 7, 2023
Postoperative events and complications of next-day stent removal following uncomplicated percutaneous nephrolithotomy compared to longer stentingTaylor Goodstein, Patrick Mershon, Tasha Posid, et al.
Urology Practice|January 20, 2026
Does the VA Risk Analysis Index Overestimate Frailty in Patients with Localized Prostate Cancer?Pranay Manda, Siddharth Marthi, Ernest Morton, et al.
Research and Reports in Urology|October 3, 2025
Preoperative β2 Microglobulin Is a Prognostic Factor in Patients with Renal Cell Carcinoma and Normal Kidney FunctionGregory Palmateer, Eduoard H Nicaise, Taylor Goodstein, et al.
Urology|April 18, 2025
Incidence of New Mental Health Diagnosis in Testicular Cancer SurvivorsSiddharth Marthi, Gregory Palmateer, Talia Helman, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Current Opinion in Oncology|April 4, 2024
Special populations in metastatic renal cell carcinomaTaylor Goodstein, Ilana Goldberg, Yusuf Acikgoz, et al.
Cancers|April 14, 2026
Using ctDNA to Inform Adjuvant Therapy for Urologic MalignanciesRajvi Goradia, Taylor Goodstein, Debasish Sundi, et al.
Translational Cancer Research|December 19, 2024
Perioperative systemic therapy in high-risk renal cell carcinoma following nephrectomy: a narrative reviewAdam Khorasanchi, Taylor Goodstein, Shawn Dason, et al.
Urologic Oncology|July 2, 2025
Concordance between clinical and pathologic staging of larger (cT2a-b) and more invasive (cT3a) renal cell carcinomaTaylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Clinical Genitourinary Cancer|March 18, 2026
Retraction notice to " Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell Carcinoma"[Clinical Genitourinary Cancer 23/6 (2025) 102422]Taylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Clinical Genitourinary Cancer|September 17, 2025
Impact of Upstaging From cT2a-b to pT3a on Overall Survival Among Patients With Renal Cell CarcinomaTaylor Goodstein, Rajvi Goradia, Arnav Srivastava, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 7, 2023
Postoperative events and complications of next-day stent removal following uncomplicated percutaneous nephrolithotomy compared to longer stentingTaylor Goodstein, Patrick Mershon, Tasha Posid, et al.
Urology Practice|January 20, 2026
Does the VA Risk Analysis Index Overestimate Frailty in Patients with Localized Prostate Cancer?Pranay Manda, Siddharth Marthi, Ernest Morton, et al.
Research and Reports in Urology|October 3, 2025
Preoperative β2 Microglobulin Is a Prognostic Factor in Patients with Renal Cell Carcinoma and Normal Kidney FunctionGregory Palmateer, Eduoard H Nicaise, Taylor Goodstein, et al.
Urology|April 18, 2025
Incidence of New Mental Health Diagnosis in Testicular Cancer SurvivorsSiddharth Marthi, Gregory Palmateer, Talia Helman, et al.
Pageof 3